Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
plenty of opportunities in the company for a dedicated employee who are capable and full of ideas
Qual é a melhor parte das suas compensações?
flexible working hours, comparable benefits in biotech
O que você mais gosta nos lideres?
vision, hands-on, determined, quick decisions
Quais são algumas das melhores coisas da sua equipe?
dedicated, learn quickly, collaborative style
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
innovative thinking, making impossible possible
O que faz você mais feliz no trabalho?
challenges possibly meet every day opportunity to provide scientific suggestions and strategies which will make significant impact on the pipeline and company growth
Other Employee Reviews for Karyopharm Therapeutics
×